Clinical Trial Update: Hospital at Home at EOL in Heme Malignancies [NA]

View source ↗

Summary

The Massachusetts General Hospital trial evaluating hospital-at-home care at end-of-life for hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hematologic Malignancy | NA | Status: COMPLETED